EcoDrugPlus

Carbonic Anhydrase Iv B

Ensembl ID : ENSMZEG00005008632
Gene Symbol: CA4B
1 Cross references
190 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSMZEG00005005827
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase I

Ensembl ID : ENSMZEG00005019304
Gene Symbol: LOC101484527
3 Cross references
196 Possible Orthologues:

Caspase 9

Ensembl ID : ENSMZEG00005021345
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSMZEG00005010499
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSMZEG00005026580
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSMZEG00005010652
Gene Symbol: LOC101486434
3 Cross references
222 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSMZEG00005010606
Gene Symbol: CTSS
4 Cross references
227 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSMZEG00005010627
Gene Symbol: CTSS
4 Cross references
229 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSMZEG00005004637
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Cellular Tumor Antigen P53

Ensembl ID : ENSMZEG00005021693
Gene Symbol: LOC101480650
2 Cross references
232 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSMZEG00005018841
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).